These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32037354)

  • 21. Clinical implications of elevated serum interleukin-6 in IgG4-related disease.
    Tsukuda S; Ikeura T; Ito T; Nakamaru K; Masuda M; Hori Y; Ikemune M; Yanagawa M; Tanaka T; Tomiyama T; Yamaguchi T; Ando Y; Uchida K; Fukui T; Nishio A; Terasawa R; Tanigawa N; Okazaki K
    PLoS One; 2020; 15(1):e0227479. PubMed ID: 31951598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 5-year-old boy with unicentric Castleman disease affecting the mesentery: utility of serum IL-6 level and (18)F-FDG PET for diagnosis.
    Toita N; Kawamura N; Hatano N; Takezaki S; Ohkura Y; Yamada M; Okano M; Okada T; Sasaki F; Kubota KC; Itoh T; Ariga T
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):693-5. PubMed ID: 19730402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease.
    Berti A; Della-Torre E; Gallivanone F; Canevari C; Milani R; Lanzillotta M; Campochiaro C; Ramirez GA; Bozzalla Cassione E; Bozzolo E; Pedica F; Castiglioni I; Arcidiacono PG; Balzano G; Falconi M; Gianolli L; Dagna L
    Rheumatology (Oxford); 2017 Dec; 56(12):2084-2092. PubMed ID: 28977663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-6 expression helps distinguish Castleman's disease from IgG4-related disease in the lung.
    Kinugawa Y; Uehara T; Iwaya M; Asaka S; Kobayashi S; Nakajima T; Komatsu M; Yasuo M; Yamamoto H; Ota H
    BMC Pulm Med; 2021 Jul; 21(1):219. PubMed ID: 34246246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indolent T-Lymphoblastic Proliferation in Idiopathic Multicentric Castleman Disease.
    Karki NR; Arfa AS; Savage N; Kutlar A
    Acta Haematol; 2022; 145(2):214-220. PubMed ID: 34818661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Classic Hodgkin lymphoma and Castleman disease: an entity appears to be emerging.
    Lyapichev KA; You MJ; Vega F; Solis LM; Medeiros LJ
    Virchows Arch; 2020 Sep; 477(3):437-444. PubMed ID: 32152665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic challenges of the idiopathic plasmacytic lymphadenopathy (IPL) subtype of idiopathic multicentric Castleman disease (iMCD): Factors to differentiate from IgG4-related disease.
    Nishikori A; Nishimura MF; Fajgenbaum DC; Nishimura Y; Maehama K; Haratake T; Tabata T; Kawano M; Nakamura N; Momose S; Sumiyoshi R; Koga T; Yamamoto H; van Rhee F; Kawakami A; Sato Y
    J Clin Pathol; 2024 Feb; ():. PubMed ID: 38378248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinicopathological comparison among nodal cases of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
    Kurose N; Futatsuya C; Mizutani KI; Kumagai M; Shioya A; Guo X; Aikawa A; Nakada S; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Kojima M; Nakamura S; Yamada S
    Hum Pathol; 2018 Jul; 77():130-138. PubMed ID: 29684500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathologic characteristics of 342 patients with multicentric Castleman disease in Japan.
    Murakami M; Johkoh T; Hayashi S; Ohshima S; Mizuki M; Nakatsuka SI; Tomobe M; Kuroyanagi K; Nakasone A; Nishimoto N
    Mod Rheumatol; 2020 Sep; 30(5):843-851. PubMed ID: 31829070
    [No Abstract]   [Full Text] [Related]  

  • 30. Interleukin-6-producing giant cell carcinoma of the lung with multicentric Castleman's disease-like presentation.
    Higashikuni Y; Mori M; Kino H
    Intern Med; 2007; 46(10):669-73. PubMed ID: 17527041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of clinical and pathological features of lung lesions of systemic IgG4-related disease and idiopathic multicentric Castleman's disease.
    Terasaki Y; Ikushima S; Matsui S; Hebisawa A; Ichimura Y; Izumi S; Ujita M; Arita M; Tomii K; Komase Y; Owan I; Kawamura T; Matsuzawa Y; Murakami M; Ishimoto H; Kimura H; Bando M; Nishimoto N; Kawabata Y; Fukuda Y; Ogura T;
    Histopathology; 2017 Jun; 70(7):1114-1124. PubMed ID: 28207938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autologous stem cell transplantation in a rare multicentric Castleman disease of the plasma cell variant.
    Tal Y; Haber G; Cohen MJ; Phillips M; Amir G; Ben-Yehuda D; Ben-Yehuda A
    Int J Hematol; 2011 May; 93(5):677-680. PubMed ID: 21437636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactive lymphadenopathy with concurrent idiopathic plasma cell variant Castleman disease, amyloid deposition and non-caseating granulomas.
    El Achi H; Glass WF; Wang W; Medeiros LJ; Hu Z
    Pathology; 2019 Dec; 51(7):762-764. PubMed ID: 31662201
    [No Abstract]   [Full Text] [Related]  

  • 34. Lymph node granulomas in immunoglobulin G4-related disease.
    Bateman AC; Ashton-Key MR; Jogai S
    Histopathology; 2015 Oct; 67(4):557-61. PubMed ID: 25620085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A high number of IgG4-positive plasma cells rules out nodular lymphocyte predominant Hodgkin lymphoma.
    Kiil K; Bein J; Schuhmacher B; Thurner L; Schneider M; Hansmann ML; Hartmann S
    Virchows Arch; 2018 Dec; 473(6):759-764. PubMed ID: 30259184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-6-producing Intravascular Large B-cell Lymphoma with Lymphadenopathy Mimicking the Histology of Multicentric Castleman Disease.
    Shiroshita K; Kikuchi T; Okayama M; Kasahara H; Kamiya T; Shimizu T; Kurose N; Masaki Y; Okamoto S
    Intern Med; 2020 Dec; 59(23):3061-3065. PubMed ID: 32759587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Not Available].
    Zen Y
    Presse Med; 2020 Apr; 49(1):104014. PubMed ID: 32234381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary Manifestations of Plasma Cell Type Idiopathic Multicentric Castleman Disease: A Clinicopathological Study in Comparison with IgG4-Related Disease.
    Nishimura MF; Igawa T; Gion Y; Tomita S; Inoue D; Izumozaki A; Ubara Y; Nishimura Y; Yoshino T; Sato Y
    J Pers Med; 2020 Dec; 10(4):. PubMed ID: 33321725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overlap of IgG4-related Disease and Multicentric Castleman's Disease in a Patient with Skin Lesions.
    Mochizuki H; Kato M; Higuchi T; Koyamada R; Arai S; Okada S; Eto H
    Intern Med; 2017; 56(9):1095-1099. PubMed ID: 28458319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Idiopathic Multicentric Castleman Disease with Strikingly Elevated IgG4 Concentration in the Serum and Abundant IgG4-Positive Cells in the Tissue: A Case Report.
    Cheng CC; Chen YC; Hsu YH; Su KY
    Diagnostics (Basel); 2022 Sep; 12(9):. PubMed ID: 36140662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.